Realty Income has a solid strategy. It largely caters to companies in non-discretionary, service-oriented, non-retail, and ...

LONDON - Haleon PLC (LSE/NYSE: HLN), a global consumer health company, announced a change to its Board of Directors today. Following the decline of Pfizer Inc. (NYSE:PFE)’s shareholding in ...

In corporate governance news, Bryan Supran, a Non-Executive Director representing Pfizer (NYSE:PFE), has stepped down from Haleon’s board following Pfizer’s reduction of its stake in the ...

Pfizer to sell $3 billion stake in Sensodyne maker Haleon Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon , lowering its stake in the British consumer healthcare ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.

Hyperinflation and high interest rates make dividend-paying stocks attractive. Read why PFE and BTI stocks could be great ...

Haleon HLN-1.12%decrease ... The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer, said Thursday that it made a pretax profit of 1.91 billion pounds ($2.42 billion ...

Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...

The Motley Fool has positions in and recommends FedEx, Home Depot, Pfizer, Realty Income, and Walmart. The Motley Fool recommends Haleon Plc and Verizon Communications. The Motley Fool has a ...

Haleon po0sted a higher pretax profit for 2024 ... The consumer-health giant, which was spun out of GSK and is partly owned by Pfizer, said Thursday that it made a pretax profit of 1.91 billion ...

Pfizer has also increased its dividend for 16 ... from the company's sale of its stake in British pharmaceutical company Haleon. Management also seems confident on its cash-flow generating ...